MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Inclusion Criteria: * African American * Receiving hemodialysis treatments * Been on hemodialysis for more than 30 days * 18 years of age and older * Within a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes. Exclusion Criteria: * Not self-identified as African American * Impaired with mental status or severe illness * Non-English speaking * No documented evidence of dialysis treatment non-adherence * Missed or shortened treatments due to hospitalizations or excused travel * Terminal condition * Living in a nursing home/rehab * Planned transplant within the next 6 months * Planned conversion to peritoneal dialysis within the next 6 months